FDA shows concern over emergency authorization of Covid-19 vaccines
The ageny may be exploring the idea of using expanded access — a more limiting program — in the early days of Covid vaccine rollouts.
Related Articles
Report calls for regulations around dangerous pathogen research
Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics at Harvard Chan School, discusses key takeaways from a new report…
Report calls for regulations around dangerous pathogen research
Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics at Harvard Chan School, discusses key takeaways from a new report…
Health Scientist (Data Scientist)
As a global leader in public health & health promotion, CDC is the agency Americans trust with their lives. In addition to our everyday work,…
Regulating Risky Research: The Science and Governance of Pathogens of Pandemic Potential
The COVID-19 pandemic has renewed public interest in gain-of-function (GOF) research of concern on pathogens of pandemic potential. Are laboratory experiments to make pathogens more…
Charting a course for better pneumococcal vaccines
A new platform for developing bacterial vaccines—the multiple antigen presenting system—could enable an affordable alternative to current pneumococcal conjugate vaccines. Here, the multiple antigen presenting…
Defining and emulating target trials of the effects of postexposure vaccination using observational data
Postexposure vaccination has the potential to prevent or modify the course of clinical disease among those exposed to a pathogen. However, due to logistical constraints,…
JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data
JYNNEOSTM vaccine has been used as post-exposure prophylaxis (PEP) during a mpox outbreak in New York City (NYC). Data on effectiveness are limited.Ef…
Reimagining our Shared Approach to Fall Respiratory Virus Seasons: New Strategies for Transmission Reduction and Population-Level Benefit
The Duke-Margolis Center for Health Policy, in collaboration with the Bill and Melinda Gates Foundation, will convene a public meeting focused on a new strategic…
Going the Distance: A Current View of Enhancer Action
In eukaryotes, transcription of genes by RNA polymerase II yields messenger RNA intermediates from which protein products are synthesized. Transcriptional enhancers are discrete DNA elements…